Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Noonan Syndrome 5 × binimetinib × Other hematologic neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other hematologic neoplasm 1

Conditions

Leukemia, Hairy Cell 2 Hematologic Neoplasms 2 Noonan Syndrome 5 1 Multiple Myeloma 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Carcinoma, Non-Small-Cell Lung 1 Blast Crisis 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01885195 2021-02-21

SIGNATURE

Pfizer

Phase 2 Completed

110 enrolled 18 charts

Other hematologic neoplasmThoracic

Noonan Syndrome 5, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡